Vapotherm, Inc. (VAPO)
USD 2.17
(-0.46%)
USD 2.17
(-0.46%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -58.19 Million USD | 48.62% |
| 2022 | -113.25 Million USD | -89.4% |
| 2021 | -59.8 Million USD | -6.38% |
| 2020 | -56.21 Million USD | -10.09% |
| 2019 | -51.05 Million USD | -20.23% |
| 2018 | -42.46 Million USD | -36.97% |
| 2017 | -31 Million USD | -34.38% |
| 2016 | -23.07 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -14.27 Million USD | 3.81% |
| 2024 Q1 | -14.83 Million USD | -45.67% |
| 2023 Q4 | -10.18 Million USD | 32.68% |
| 2023 Q2 | -14.78 Million USD | 18.25% |
| 2023 Q1 | -18.09 Million USD | 15.61% |
| 2023 Q3 | -15.13 Million USD | -2.31% |
| 2023 FY | -58.19 Million USD | 48.62% |
| 2022 Q4 | -21.43 Million USD | 18.18% |
| 2022 Q1 | -22.93 Million USD | -23.59% |
| 2022 FY | -113.25 Million USD | -89.4% |
| 2022 Q2 | -42.68 Million USD | -86.08% |
| 2022 Q3 | -26.2 Million USD | 38.61% |
| 2021 FY | -59.8 Million USD | -6.38% |
| 2021 Q3 | -13.56 Million USD | 21.43% |
| 2021 Q2 | -17.26 Million USD | -65.92% |
| 2021 Q1 | -10.4 Million USD | 39.44% |
| 2021 Q4 | -18.56 Million USD | -36.81% |
| 2020 FY | -56.21 Million USD | -10.09% |
| 2020 Q4 | -17.18 Million USD | -38.11% |
| 2020 Q1 | -13.84 Million USD | -11.2% |
| 2020 Q3 | -12.44 Million USD | -54.91% |
| 2020 Q2 | -8.03 Million USD | 41.98% |
| 2019 Q1 | -12.96 Million USD | -0.68% |
| 2019 Q4 | -12.45 Million USD | 2.47% |
| 2019 Q3 | -12.76 Million USD | 0.89% |
| 2019 Q2 | -12.88 Million USD | 0.65% |
| 2019 FY | -51.05 Million USD | -20.23% |
| 2018 Q2 | -11.22 Million USD | -26.05% |
| 2018 FY | -42.46 Million USD | -36.97% |
| 2018 Q4 | -12.87 Million USD | -36.13% |
| 2018 Q1 | -8.9 Million USD | 1.38% |
| 2018 Q3 | -9.45 Million USD | 15.74% |
| 2017 Q3 | -7.66 Million USD | -3.25% |
| 2017 Q4 | -9.03 Million USD | -17.88% |
| 2017 FY | -31 Million USD | -34.38% |
| 2017 Q1 | -7.21 Million USD | 0.0% |
| 2017 Q2 | -7.42 Million USD | -2.88% |
| 2016 FY | -23.07 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Abbott Laboratories | 5.72 Billion USD | 101.017% |
| Allurion Technologies Inc. | -82.3 Million USD | 29.295% |
| Artivion, Inc. | -30.69 Million USD | -89.616% |
| Avanos Medical, Inc. | -61.8 Million USD | 5.837% |
| Butterfly Network, Inc. | -133.69 Million USD | 56.475% |
| Butterfly Network, Inc. | -133.69 Million USD | 56.475% |
| Bio-Rad Laboratories, Inc. | -637.32 Million USD | 90.869% |
| Boston Scientific Corporation | 1.59 Billion USD | 103.653% |
| Perspective Therapeutics, Inc. | -14.67 Million USD | -296.68% |
| CONMED Corporation | 64.45 Million USD | 190.279% |
| Edwards Lifesciences Corporation | 1.4 Billion USD | 104.15% |
| Paragon 28, Inc. | -47.84 Million USD | -21.638% |
| Glaukos Corporation | -134.66 Million USD | 56.786% |
| Globus Medical, Inc. | 122.87 Million USD | 147.36% |
| Inspire Medical Systems, Inc. | -21.15 Million USD | -175.105% |
| Integer Holdings Corporation | 90.65 Million USD | 164.195% |
| Medtronic plc | 3.67 Billion USD | 101.583% |
| Nevro Corp. | -92.21 Million USD | 36.893% |
| Owlet, Inc. | -32.9 Million USD | -76.873% |
| Penumbra, Inc. | 90.95 Million USD | 163.981% |
| Vicarious Surgical Inc. | -71.07 Million USD | 18.12% |
| Smith & Nephew plc | 263 Million USD | 122.127% |
| Sonendo, Inc. | -60.91 Million USD | 4.475% |
| STERIS plc | 378.23 Million USD | 115.385% |
| Stryker Corporation | 3.16 Billion USD | 101.839% |
| Zimmer Biomet Holdings, Inc. | 1.02 Billion USD | 105.683% |